CONDENSED CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
ASSETS
Cash and cash equivalents, $2,514 reserved at September 30, 2013	$ 7,183	$ 10,205
Other current assets	83	383
Total current assets	7,266	10,588
Patent license rights, net	862	980
Furniture and equipment, net	5	23
Total assets	8,133	11,591
LIABILITIES AND EQUITY
Accounts payable	200	233
Other accrued liabilities	6	61
Total current liabilities	206	294
Equity
Common Stock $.0005 par value; 100,000,000 shares authorized; 40,885,411 shares in 2013 and 2012 issued and outstanding	20	20
Additional paid-in capital	189,210	189,181
Accumulated deficit ($153,541at September 30, 2013 and $150,335 at December 31, 2012, accumulated during development stage period)	(181,303)	(178,097)
Total Capstone Therapeutics Corp. stockholders' equity	7,927	11,104
Noncontrolling interest	0	193
Total equity	7,927	11,297
Total liabilities and equity	$ 8,133	$ 11,591